Trial Search Results
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study hematopoietic stem cell transplantation. A secondary purpose of the database is to have a comprehensive source of data to study marrow toxic injuries.
Stanford is currently accepting patients for this trial.
Center for International Blood and Marrow Transplant Research
Eligibility to Participate in the Research Database
Recipient Eligibility Criteria:
- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.
Individual with Marrow Toxic Injury Eligibility Criteria:
- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making capacity,
and children. Eligible individuals may have received supportive care only, growth
factor support, HSC transplant or other appropriate medical treatment for marrow toxic
injury. Treatments applied are at the discretion of the care facility, and are not
determined by the NMDP or CIBMTR.
Unrelated Donor Eligibility Criteria:
- All donors registered on the NMDP Registry who have been requested to donate a product
for a recipient are eligible to participate in the Research Database.
- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study